Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies

Identifieur interne : 001159 ( Main/Exploration ); précédent : 001158; suivant : 001160

[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies

Auteurs : Brad A. Racette [États-Unis] ; Laura Good [États-Unis] ; Jo Ann Antenor [États-Unis] ; Lori Mcgee-Minnich [États-Unis] ; Stephen M. Moerlein [États-Unis] ; Tom O. Videen [États-Unis] ; Joel S. Perlmutter [États-Unis]

Source :

RBID : ISTEX:1120A148AA1AA58ADCB15CC8CB8C70DCD377EC84

English descriptors

Abstract

Parkinson disease (PD) is a late onset disorder with age‐dependent penetrance that may confound genetic studies, since affected individuals may not demonstrate clinical manifestations at the time of evaluation. The use of endophenotypes, biologic surrogates for clinical disease diagnoses, may permit more accurate classification of at‐risk subjects. Positron emission tomography (PET) measurements of 6‐[18F]fluorodopa ([18F]FDOPA) uptake indicate nigrostriatal neuronal integrity and may provide a useful endophenotype for PD linkage studies. We performed [18F]FDOPA PET in 11 members of a large, multi‐incident Amish family with PD, 24 normals and 48 people with clinically definite idiopathic PD (PD controls). Clinical diagnoses in the Amish were clinically definite PD in four, clinically probable in one, clinically possible in five, and normal in one. Abnormal [18F]FDOPA posterior putamen uptake was defined as less than 3 standard deviations below the normal mean. The criteria were applied to the Amish sample to determine a PET endophenotype for each. We performed genetic simulations using SLINK to model the effect phenoconversion with the PET endophenotype had on logarithm of odds (LOD) scores. PET endophenotype confirmed the status of two clinically definite subjects. Two clinically definite Amish PD subjects had normal PETs. Two possible PD were converted to “PET definite PD.” The remainder had normal PETs. The average maximum LOD score with the pre‐PET was 6.14 ± 0.84. Simulating phenoconversion of subjects with unknown phenotypes increased the LOD score to 7.36 ± 1.23. The [18F]FDOPA PET endophenotype permits phenoconversion in multi‐incident PD families and may increase LOD score accuracy and power of an informative pedigree. © 2006 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/ajmg.b.30293


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies</title>
<author>
<name sortKey="Racette, Brad A" sort="Racette, Brad A" uniqKey="Racette B" first="Brad A." last="Racette">Brad A. Racette</name>
</author>
<author>
<name sortKey="Good, Laura" sort="Good, Laura" uniqKey="Good L" first="Laura" last="Good">Laura Good</name>
</author>
<author>
<name sortKey="Antenor, Jo Ann" sort="Antenor, Jo Ann" uniqKey="Antenor J" first="Jo Ann" last="Antenor">Jo Ann Antenor</name>
</author>
<author>
<name sortKey="Mcgee Innich, Lori" sort="Mcgee Innich, Lori" uniqKey="Mcgee Innich L" first="Lori" last="Mcgee-Minnich">Lori Mcgee-Minnich</name>
</author>
<author>
<name sortKey="Moerlein, Stephen M" sort="Moerlein, Stephen M" uniqKey="Moerlein S" first="Stephen M." last="Moerlein">Stephen M. Moerlein</name>
</author>
<author>
<name sortKey="Videen, Tom O" sort="Videen, Tom O" uniqKey="Videen T" first="Tom O." last="Videen">Tom O. Videen</name>
</author>
<author>
<name sortKey="Perlmutter, Joel S" sort="Perlmutter, Joel S" uniqKey="Perlmutter J" first="Joel S." last="Perlmutter">Joel S. Perlmutter</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:1120A148AA1AA58ADCB15CC8CB8C70DCD377EC84</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/ajmg.b.30293</idno>
<idno type="url">https://api.istex.fr/document/1120A148AA1AA58ADCB15CC8CB8C70DCD377EC84/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000529</idno>
<idno type="wicri:Area/Main/Curation">000459</idno>
<idno type="wicri:Area/Main/Exploration">001159</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">[18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies</title>
<author>
<name sortKey="Racette, Brad A" sort="Racette, Brad A" uniqKey="Racette B" first="Brad A." last="Racette">Brad A. Racette</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Department of Neurology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>American Parkinson Disease Association Advanced Center for Parkinson Research, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Good, Laura" sort="Good, Laura" uniqKey="Good L" first="Laura" last="Good">Laura Good</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Department of Neurology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>American Parkinson Disease Association Advanced Center for Parkinson Research, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Antenor, Jo Ann" sort="Antenor, Jo Ann" uniqKey="Antenor J" first="Jo Ann" last="Antenor">Jo Ann Antenor</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Department of Neurology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Mcgee Innich, Lori" sort="Mcgee Innich, Lori" uniqKey="Mcgee Innich L" first="Lori" last="Mcgee-Minnich">Lori Mcgee-Minnich</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Department of Neurology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>American Parkinson Disease Association Advanced Center for Parkinson Research, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Moerlein, Stephen M" sort="Moerlein, Stephen M" uniqKey="Moerlein S" first="Stephen M." last="Moerlein">Stephen M. Moerlein</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Videen, Tom O" sort="Videen, Tom O" uniqKey="Videen T" first="Tom O." last="Videen">Tom O. Videen</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Department of Neurology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Perlmutter, Joel S" sort="Perlmutter, Joel S" uniqKey="Perlmutter J" first="Joel S." last="Perlmutter">Joel S. Perlmutter</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Department of Neurology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>American Parkinson Disease Association Advanced Center for Parkinson Research, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Department of Anatomy & Neurobiology, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Program in Physical Therapy, Washington University School of Medicine, St. Louis</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">American Journal of Medical Genetics Part B: Neuropsychiatric Genetics</title>
<title level="j" type="abbrev">Am. J. Med. Genet.</title>
<idno type="ISSN">1552-4841</idno>
<idno type="eISSN">1552-485X</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-04-05">2006-04-05</date>
<biblScope unit="volume">141B</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="245">245</biblScope>
<biblScope unit="page" to="249">249</biblScope>
</imprint>
<idno type="ISSN">1552-4841</idno>
</series>
<idno type="istex">1120A148AA1AA58ADCB15CC8CB8C70DCD377EC84</idno>
<idno type="DOI">10.1002/ajmg.b.30293</idno>
<idno type="ArticleID">AJMG30293</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1552-4841</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amish</term>
<term>Parkinson's disease</term>
<term>endophenotype</term>
<term>linkage</term>
<term>positron emission tomography</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Parkinson disease (PD) is a late onset disorder with age‐dependent penetrance that may confound genetic studies, since affected individuals may not demonstrate clinical manifestations at the time of evaluation. The use of endophenotypes, biologic surrogates for clinical disease diagnoses, may permit more accurate classification of at‐risk subjects. Positron emission tomography (PET) measurements of 6‐[18F]fluorodopa ([18F]FDOPA) uptake indicate nigrostriatal neuronal integrity and may provide a useful endophenotype for PD linkage studies. We performed [18F]FDOPA PET in 11 members of a large, multi‐incident Amish family with PD, 24 normals and 48 people with clinically definite idiopathic PD (PD controls). Clinical diagnoses in the Amish were clinically definite PD in four, clinically probable in one, clinically possible in five, and normal in one. Abnormal [18F]FDOPA posterior putamen uptake was defined as less than 3 standard deviations below the normal mean. The criteria were applied to the Amish sample to determine a PET endophenotype for each. We performed genetic simulations using SLINK to model the effect phenoconversion with the PET endophenotype had on logarithm of odds (LOD) scores. PET endophenotype confirmed the status of two clinically definite subjects. Two clinically definite Amish PD subjects had normal PETs. Two possible PD were converted to “PET definite PD.” The remainder had normal PETs. The average maximum LOD score with the pre‐PET was 6.14 ± 0.84. Simulating phenoconversion of subjects with unknown phenotypes increased the LOD score to 7.36 ± 1.23. The [18F]FDOPA PET endophenotype permits phenoconversion in multi‐incident PD families and may increase LOD score accuracy and power of an informative pedigree. © 2006 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Missouri (État)</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Missouri (État)">
<name sortKey="Racette, Brad A" sort="Racette, Brad A" uniqKey="Racette B" first="Brad A." last="Racette">Brad A. Racette</name>
</region>
<name sortKey="Antenor, Jo Ann" sort="Antenor, Jo Ann" uniqKey="Antenor J" first="Jo Ann" last="Antenor">Jo Ann Antenor</name>
<name sortKey="Good, Laura" sort="Good, Laura" uniqKey="Good L" first="Laura" last="Good">Laura Good</name>
<name sortKey="Good, Laura" sort="Good, Laura" uniqKey="Good L" first="Laura" last="Good">Laura Good</name>
<name sortKey="Mcgee Innich, Lori" sort="Mcgee Innich, Lori" uniqKey="Mcgee Innich L" first="Lori" last="Mcgee-Minnich">Lori Mcgee-Minnich</name>
<name sortKey="Mcgee Innich, Lori" sort="Mcgee Innich, Lori" uniqKey="Mcgee Innich L" first="Lori" last="Mcgee-Minnich">Lori Mcgee-Minnich</name>
<name sortKey="Moerlein, Stephen M" sort="Moerlein, Stephen M" uniqKey="Moerlein S" first="Stephen M." last="Moerlein">Stephen M. Moerlein</name>
<name sortKey="Perlmutter, Joel S" sort="Perlmutter, Joel S" uniqKey="Perlmutter J" first="Joel S." last="Perlmutter">Joel S. Perlmutter</name>
<name sortKey="Perlmutter, Joel S" sort="Perlmutter, Joel S" uniqKey="Perlmutter J" first="Joel S." last="Perlmutter">Joel S. Perlmutter</name>
<name sortKey="Perlmutter, Joel S" sort="Perlmutter, Joel S" uniqKey="Perlmutter J" first="Joel S." last="Perlmutter">Joel S. Perlmutter</name>
<name sortKey="Perlmutter, Joel S" sort="Perlmutter, Joel S" uniqKey="Perlmutter J" first="Joel S." last="Perlmutter">Joel S. Perlmutter</name>
<name sortKey="Perlmutter, Joel S" sort="Perlmutter, Joel S" uniqKey="Perlmutter J" first="Joel S." last="Perlmutter">Joel S. Perlmutter</name>
<name sortKey="Racette, Brad A" sort="Racette, Brad A" uniqKey="Racette B" first="Brad A." last="Racette">Brad A. Racette</name>
<name sortKey="Videen, Tom O" sort="Videen, Tom O" uniqKey="Videen T" first="Tom O." last="Videen">Tom O. Videen</name>
<name sortKey="Videen, Tom O" sort="Videen, Tom O" uniqKey="Videen T" first="Tom O." last="Videen">Tom O. Videen</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001159 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001159 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:1120A148AA1AA58ADCB15CC8CB8C70DCD377EC84
   |texte=   [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024